Hims & Hers Health, Inc. (HIMS) Q3 Revenues Beat; Guides Above

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q3 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $74.2 million versus the consensus estimate of $70.53 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q4 2021 revenue of $76-78 million, versus the consensus of $70.13 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Green Dot and CommerceOne shareholders approve acquisition deal